We recently published a list of the 15 Best Dividend Aristocrat Stocks with Over 3% Yield. In this article, we are going to ...
21h
MedPage Today on MSNEvolut Low Risk TAVR Still Chugging Along, Now Halfway to Trial's Finish LineCHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at ...
Medtronic (NYSE:MDT) recently saw a substantial price movement, climbing 10% over the last quarter. This period was marked by ...
Medtronic's stock has lost around a third of its value since late 2022. However, stock prices for longtime dividend growers ...
Medtronic (MDT) shares snapped seven straight days of losses as the stock closed xx% higher, at $xx on Thursday. The medical ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Explore more
Shares of Medtronic PLC MDT shed 1.71% to $88.59 Tuesday, on what proved to be an all-around positive trading session for the ...
Three Intel board members will not stand for reelection at its 2025 annual meeting, the chipmaker said in a regulatory filing ...
Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...
Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...
The SINGLE SHOT CHAMPION study increases momentum for PFA as a first-line option for pulmonary vein isolation, say experts.
Icovy Marketing, a MedTech-focused growth and commercialization partner, will participate in DeviceTalks Boston April 30–May ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results